Current issue
1/2020 vol. 10
Dear Colleagues, I invite you to read the first number of Journal of Hearing Science for 2020. From the very beginning of this year, all of us have been placed in a difficult situation: dealing with a new virus, SARS-CoV-2, which very quickly has spread around the world. A global search for specific vaccines or drugs to treat this virus may eventually help improve the situation, although it is a very costly and time-consuming undertaking. As part of a need for more knowledge about how to deal with SARS-CoV-2, we start the current issue with a review paper that tackles one aspect of this problem. The paper by Skarżyńska and colleagues looks at drugs that have already been approved in different parts of the world to treat SARS-CoV-2 and examines the ototoxic side-effects of these drugs, a factor that will be in the minds of many ENT practitioners. The issue follows with more traditional topics. First, there is a review of difficulties associated with performing magnetic resonance imaging in patients with cochlear implants. This is an important consideration in the development of cochlear implants which still allow the patient to undergo an MRI. Next there is a paper dealing with the performance of hearing aids and another on testing the postural stability of the elderly and reducing their risk of falls by undertaking a dedicated training program. The issue concludes with an interesting case study of the recovery of a patient after reconstruction of the laryngeal nerves. With kind regards and greetings, Prof. Henryk Skarzynski, M.D., Ph.D., Dr. h.c. multi


J Hear Sci 2020;10(1):5